HF-CRT Echo Resynchronization Index Calculator

Clinical calculation support · Verify results before clinical use

Post-CRT Echocardiographic Assessment

Enter baseline and follow-up measurements to quantify LV reverse remodeling and review dyssynchrony measurements.

ReadyAssessment
Measured before CRT implantation.
Use a follow-up measurement and timing appropriate to the clinical protocol.
Enter a measured value only if assessed using your laboratory's specified method.
Record the method and acquisition conditions in the clinical record.
Electrical timing is displayed separately; it is not converted to an unvalidated composite score.
—LVESV change
Echocardiographic follow-up

Enter measurements to calculate

The calculator will report the percentage change in LVESV and compare it with the commonly used ≥15% reverse-remodeling criterion.

Baseline LVESV—
Follow-up LVESV—
Change in LVESV—
Septal-to-lateral delayNot entered
IVMDNot entered
Baseline QRS durationNot entered

This is a measurement aid, not a validated composite HF-CRT Echo Resynchronization Index. No composite score, probability of response, or treatment recommendation is generated because a validated formula and cutoff for such an index could not be verified.

Clinical context and calculation

Cardiac resynchronization therapy response is multidimensional. Echocardiographic response may include a reduction in LV size or volume, improvement or stability in LVEF, increased LV stroke volume, and reduced mitral regurgitation. Clinical response may include improved symptoms, functional status, quality of life, or fewer heart-failure hospitalizations.

Calculation

MeasureFormula or interpretation
LVESV reduction (%)((Baseline LVESV − Follow-up LVESV) / Baseline LVESV) × 100
Reverse remodeling criterionLVESV reduction ≥15% is commonly used in studies; response definitions vary by study and follow-up time.
Timing parametersSeptal-to-lateral delay, IVMD, and QRS duration are displayed individually and are not combined into an unvalidated score.

Interpretation limits

  • A ≥15% LVESV reduction supports an echocardiographic reverse-remodeling response by this commonly used research definition; it does not establish overall clinical benefit by itself.
  • A reduction below 15%, no change, or an increase in LVESV does not independently determine CRT failure or the next treatment step.
  • Echo dyssynchrony measurements are technique-dependent. Current CRT selection should not be based on a single echocardiographic dyssynchrony measure alone.
  • Interpret results with image quality, acquisition method, follow-up interval, LVEF, symptoms, rhythm, ECG, device capture, lead position, and guideline-directed medical therapy.

References

Chung MK, Patton KK, Lau CP, et al. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023;20(9):e17–e91. DOI: 10.1016/j.hrthm.2023.03.1538
Park JH, Negishi K, Grimm RA, et al. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events. Circ Cardiovasc Imaging. 2013;6(6):864–872. DOI: 10.1161/CIRCIMAGING.112.000026
Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44(9):1834–1840. DOI: 10.1016/j.jacc.2004.08.016
Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105(4):438–445. DOI: 10.1161/hc0402.102623
Clinical disclaimer: This tool supports quantitative review of echocardiographic follow-up and is not a substitute for clinical assessment or guideline-based CRT decisions. Do not use the displayed measurements alone to determine eligibility for CRT, device optimization, or changes in treatment.